Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics.
Sign up today and learn more about Biofourmis Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Biofourmis Stock
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers. Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts.
Founder & CEO
Kuldeep Singh Rajput
CO-Founder & MD
Chief Product Officer
VP, Data Science
VP Of Software Development
VP, Human Resources
Chief Technology Officer
Board member and Medical Advisor